Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.002 Å; R factor = 0.029; wR factor = 0.073; data-to-parameter ratio = 11.0. organic compounds o586 Oliveira et al.
In the title compound, C 7 H 11 NO 4 , prepared via a Morita-Baylis-Hillman adduct, the five-membered ring bearing three O atoms approximates to a twisted conformation, whereas the other ring is close to an envelope, with a C atom in the flap position. The dihedral angle between their mean planes (all atoms) is 23.11 (9) . The new stereocenters are created in a trans-diaxial configuration. In the crystal, O-HÁ Á ÁO and O-HÁ Á Á(O,O) hydrogen bonds link the molecules, generating a three-dimensional network. A weak C-HÁ Á ÁO interaction also occurs.
Related literature
For the utilization of this type of pyrrolizidinone as an inihibitor of glicosidase, see: D'Alanzo et al. (2009) ; Ayad et al. (2004) and for their huge therapeutical potential for the treatment of a number of diseases such as cancer, diabetes, and lysosomal storage disorders, see: Baumann (2007) . For related literature concerning preparation of the title compound, see: Freire et al. (2007) . Analysis of the absolute structure was also performed using likelihood methods, see: Hooft et al. (2008) . Table 1 Hydrogen-bond geometry (Å , ). Symmetry codes: (i) Àx þ 1; y À 1 2 ; Àz þ 2; (ii) Àx þ 1; y þ 1 2 ; Àz þ 1; (iii) Àx; y þ 1 2 ; Àz þ 1; (iv) x À 1; y; z À 1.
Experimental
Data collection: APEX2 (Bruker, 2010); cell refinement: SAINT (Bruker, 2010); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: WinGX (Farrugia,1999) and PLATON (Spek, 2009) ; software used to prepare material for publication: publCIF (Westrip, 2010) and PLATON. supplementary materials Acta Cryst. (2012) . E68, o586 [doi:10.1107/S1600536812002292] (1S,2R,6R,7aS)-1,2,6-Trihydroxyhexahydro-1H-pyrrolizin-3-one F. L. Oliveira, K. R. L. Freire, R. Aparicio and F. Coelho Comment Crystallographic data of the title polyhydroxylated pyrrolizidinone are disclosed. Compounds of this class can be used as glycosidase inhibitors and present a huge therapeutical potential for the treatment of a number of diseases such as cancer, diabetes, and lysosomal storage disorders (Baumann, 2007) . The title compound has been prepared, for the first time, using a synthetic strategy based on a Morita-Baylis-Hillman adduct, easily obtained from a reaction between N-Boc-4(R)hydroxy-2(S)-prolinal and methyl acrylate in 70% yield, as a mixture of diastereoisomers. After chromatographic separation, the minor isomer was transformed into the title compound. This compound was synthesized in five steps and 5.2% overall yield.
The asymmetric pyrrolizidinone, C 7 H 11 NO 4 , a new molecule with four stereocenters from a Morita-Baylis-Hillman adduct is shown in Fig. 1 . The crystal packing (Fig. 2) is stabilized by hydrogen bonds. The dihedral angles of H7-C7-C6-H6 = 153.8° and H1A-C1-C7-H7 = 161.6° show that the H atoms 1A, 7 and 6 of the two new stereocenters are created in the trans-diaxial configuration. These values agree with the coupling constants values obtained for these protons in the 1 H NMR analysis, 3 J H6,H7 = 7.2 Hz e 3 J H1A,H7 = 8.8 Hz. The crystallography parameters for this new molecule confirm its absolute configuration.
A solution of pyrrolizidinone (II) (0.10 g, 0.59 mmol) in MeOH/CH 2 Cl 2 (3:7, 15 mL) was cooled to -72°C. After that a stream of oxygen/ozone was bubbled into it for 8-10 min (the reaction evolution was followed by TLC). Then, NaBH 4 (0.112 g, 4.45 mmol) was added at -72°C and the resulting mixture was stirred for 6 h at room temperature. The reaction medium was initially acidified to pH 2-3 with a solution of HCl in methanol, then it was neutralized to pH 6-7 with solid Na 2 CO 3 . The resulting mixture was filtered over a pad of Celite (R) and the solid was washed with methanol. The filtrates were combined and the solvents were removed under reduced pressure. The residue was purified by flash silica gel column chromatography (CH 2 Cl 2 :MeOH 95:05) to afford pyrrolizidinone I (0.08 g), as a white solid, in 80% yield. The title compound was recrystallized by using the liquid-vapor saturation method. The compound was dissolved with ethanol and crystallized with a vapor pressure of a second less polar liquid (chloroform), in a closed camera, providing the slow formation of crystals.
[α] D 20 + 3 (c 1, MeOH); M. p. 150-152°C; IR (KBr, v max ): 3499, 3374, 2993, 2910, 1681, 1446, 1362, 1327, 1262, 1129, 1111, 1014 
Refinement
The calculated Flack parameter was F=0.20 (17) (Flack, 1983) . Analysis of the absolute structure was also performed using likelihood methods (Hooft et al., 2008) as implemented in PLATON (Spek, 2009 ). The resulting value for the Hooft parameter was y=0.12 (4), with a corresponding probability for an inverted structure smaller than 1 × 10 -100 . Taken togheter, these results indicate that the absolute structure has been determined correctly.
Computing details
Data collection: APEX2 (Bruker, 2010); cell refinement: SAINT (Bruker, 2010); data reduction: SAINT (Bruker, 2010); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: WinGX (Farrugia,1999) and PLATON (Spek, 2009) ; software used to prepare material for publication: publCIF (Westrip, 2010) and PLATON (Spek, 2009) . Title compound involved into hydrogen bonds. The presence of several hydroxyl groups in its structure leads this compound to behave as a sugar.
Figure 3
The conversion of (I) to pyrrolizidinone (II). Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
(1S,2R,6R,7aS)-1,2,6-Trihydroxyhexahydro-1H-pyrrolizin-3-one

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq O1 0.6971 (2) −0.03528 (7) (5) C1 0.0175 (7) 0.0110 (7) 0.0111 (8) 0.0019 (6) 0.0007 (6) 0.0014 (5) C2 0.0196 (7) 0.0140 (8) 0.0086 (7) −0.0004 (6) 0.0021 (6) −0.0007 (6) C3 0.0172 (7) 0.0116 (8) 0.0130 (7) −0.0010 (6) −0.0009 (6) −0.0009 (6) C4 0.0185 (8) 0.0093 (7) 0.0124 (7) 0.0001 (6) 0.0007 (6) 0.0006 (5) C5 0.0213 (7) 0.0106 (8) 0.0097 (7) 0.0001 (6) −0.0005 (6) 0.0014 (6) C6 0.0152 (7) 0.0113 (8) 0.0098 (7) 0.0010 (6) −0.0005 (6) 0.0003 (6) C7 0.0151 (7) 0.0120 (7) 0.0114 (7) 0.0002 (6) −0.0007 (6) 0.0020 (6) Geometric parameters (Å, º) Symmetry codes: (i) −x+1, y−1/2, −z+2; (ii) −x+1, y+1/2, −z+1; (iii) −x, y+1/2, −z+1; (iv) x−1, y, z−1.
